In-Drug Eluting Stent Restenosis Treated By Paclitaxel Coated Balloon Angioplasty: Results From The French Prospective Garo Registry - Marc Bedossa, MD

↳ This is a section part of Moment: CRT 2015 - Best Abstracts Session I

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$5.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

In-Drug Eluting Stent Restenosis Treated By Paclitaxel Coated Balloon Angioplasty: Results From The French Prospective Garo Registry presented by Marc Bedossa, MD at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$5.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

Interventional Cardiologists
Interventional Fellows
Interventional Radiologists
Vascular Surgeons

Session Name: Best Abstracts Session I

Learning Objectives

Updates in the Best Abstracts to feature at CRT 2015

Other Components in this Moment

Overview

Mesenchymal Stem Cells Exposed to Chronic Hypoxia Preferentially Home to Regions of Myocardial Injury Following Intravenous Injection - Michael J. Lipinski, MD, PhD

Multimodality Imaging Demonstrating Liposomes Preferentially Home to Regions of Myocardial Injury - Michael J. Lipinski, MD, PhD

In-Drug Eluting Stent Restenosis Treated By Paclitaxel Coated Balloon Angioplasty: Results From The French Prospective Garo Registry - Marc Bedossa, MD

The Role of Conventional Percutaneous Coronary Intervention, Manual Thrombectomy and Mechanical Thrombectomy during Primary Percutaneous Coronary Intervention for ST-segment Elevation Myocardial Infarction: A Network Meta-Analysis of Randomized Trials